Cerebrotendinous Xanthomatosis (CTX) clinical trials at UC Health
1 research study open to new patients
open to eligible people ages 2-21
This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.
at UCSD UCLA